Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 29 results found. Search for [ Itolizumab ]

Results 1 to 21 of 29
PB Jayakumar
May 27, 2021
Zydus is the only Indian company which claims to have developed a neutralising monoclonal antibodies (mAbs) based cocktail for the treatment of COVID 19


PTI
May 8, 2021
Addressing a press conference, Paul said the fungal infection called mucormycosis, to a large extent, is happening to people with diabetes. It is very uncommon in those who are not diabetic


BusinessToday.In
April 29, 2021
Biocon's revenue for the said quarter stood at Rs 2,044 crore, showing a growth of 26 per cent. Its EBITDA grew 68 per cent to Rs 641 crore in Q4 of the financial year


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


BusinessToday.In
September 10, 2020
AstraZeneca on Wednesday \"voluntarily\" paused the phase 3 clinical trials after a volunteer developed an \"unexplained\" illness; in India, Serum Institute, one of the partners of University of Oxford, also decided to pause the trials following the DCGI notice


BusinessToday.In
August 18, 2020
Replying to her tweet, Congress MP Shashi Tharoor said, 'So sorry to hear this. We need you hale and hearty soon! Be well, my friend'


BusinessToday.In
August 18, 2020
\"I have added to the Covid count by testing positive. Mild symptoms n I hope it stays that way,\" Kiran Mazumdar Shaw said in a tweet


PTI
July 24, 2020
Biocon said it plans to carry out a phase IV trial in 200 Covid-19 patients to know the therapeutic efficacy of Itolizumab across the country in 10-15 hospitals


BusinessToday.In
July 24, 2020
India Stock Market Highlights Today: HDFC, followed by Axis Bank, Asian Paints, SBI, ICICI Bank, Kotak Bank, IndusInd Bank and HDFC Bank. On the other hand, Sun Pharma, Reliance Industries, Tech Mahindra and Infosys were among the gainers


BusinessToday.In
July 22, 2020
Coronavirus treatment: Patients who were administered Glenmark's FabiFlu saw 40 per cent faster achievement of clinical cure


PB Jayakumar
July 21, 2020
Glenmark says compared to other therapies approved for emergency use in COVID-19 in India, FabiFlu is much more economical and an effective treatment option; DCGI had earlier asked it to clarify on allegation that the drug was unaffordable due to its high pricing


Rupa Burman Roy
July 14, 2020
Investors got spooked as coronavirus cases continued to rise in US and other parts of the world. Worldwide, the number of COVID-19 cases has crossed 1.30 crore In India, the number of infections spiked to 9.06 lakh.


BusinessToday.In
July 14, 2020
Besides Maruti Suzuki, shares of Eicher Motors and Bosch were down 3% each, followed by over 2% drop in Hero MotoCorp, Tata Motors and Motherson Sumi System


BusinessToday.In
July 14, 2020
Biocon share has risen 7.78% in the last 5 days of gains. The stock opened with a gain of 2.03% and later touched an intraday high of Rs 435.25, rising 4.98% against yesterday's close of Rs 414.60 on BSE


BusinessToday.In
July 14, 2020
Stock Market Highlights on July 14: IndusInd Bank, Bajaj Finserv, Axis Bank, Bajaj Finance, Maruti and SBI were among the other laggards. On the other hand, HCL Tech, Infosys, Nestle India, UltraTech Cement and ITC were the gainers.


BusinessToday.In
July 14, 2020
Stocks to watch today on July 14: Biocon, Wipro, Mindtree, Motherson Sumi, ITC among others are the top stocks to watch out for in Tuesday's trading session.


BusinessToday.In
July 13, 2020
Share price of Biocon rose 9.90% to  Rs 455 against previous close of Rs 414.30 on BSE


BusinessToday.In
July 13, 2020
Stocks to watch today on July 13: RIL, Yes Bank, Avenue Supermarts, IRCTC, SAIL, Biocon among others are the top stocks to watch out for in Monday's trading session.


Reuters
July 13, 2020
Thailand's first facility should complete production in October and send the products to a second facility, which should finish by November


E Kumar Sharma
July 11, 2020
Coronavirus: Biocon founder and chairperson Kiran Mazumdar Shaw says that in a matter of about 120 days the company has moved from applying for commencement of trials on coronavirus patients to getting the final approval for commercialisation


PAGES 1 OF 2  12